Gene · 4485
Papers4,329
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 4,329
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling. | Cell Death Dis | 2023 | 37454211 | PubTator, text mining | PubMed |
| The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment. | Cancers (Basel) | 2023 | 37444578 | PubTator, text mining | PubMed |
| Caring for critically ill patients with a mental illness: A discursive paper providing an overview and case exploration of the delivery of intensive care to people with psychiatric comorbidity. | Nurs Open | 2023 | 37443430 | PubTator, text mining | PubMed |
| MAP4Ks inhibition promotes retinal neuron regeneration from Müller glia in adult mice. | NPJ Regen Med | 2023 | 37443319 | PubTator, text mining | PubMed |
| Asbestos accelerates disease onset in a genetic model of malignant pleural mesothelioma. | Front Toxicol | 2023 | 37441092 | PubTator, text mining | PubMed |
| Diabetes of the Exocrine Pancreas: Implications for Pharmacological Management. | Drugs | 2023 | 37410209 | PubTator, text mining | PubMed |
| Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas. | Biomark Res | 2023 | 37403120 | PubTator, text mining | PubMed |
| Causal associations between cardiorespiratory fitness and type 2 diabetes. | Nat Commun | 2023 | 37400433 | PubTator, text mining | PubMed |
| Natural compounds targeting mitochondrial dysfunction: emerging therapeutics for target organ damage in hypertension. | Front Pharmacol | 2023 | 37397478 | PubTator, text mining | PubMed |
| Inducible Protein Degradation as a Strategy to Identify Phosphoprotein Phosphatase 6 Substrates in RAS-Mutant Colorectal Cancer Cells. | Mol Cell Proteomics | 2023 | 37392812 | PubTator, text mining | PubMed |
| Neural plasticity and depression treatment. | IBRO Neurosci Rep | 2023 | 37388497 | PubTator, text mining | PubMed |
| Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ Modulation. | J Am Chem Soc | 2023 | 37385602 | PubTator, text mining | PubMed |
| The Promise of Single-Cell RNA Sequencing to Redefine the Understanding of Crohn's Disease Fibrosis Mechanisms. | J Clin Med | 2023 | 37373578 | PubTator, text mining | PubMed |
| Denosumab Attenuates Glucolipotoxicity-Induced β-Cell Dysfunction and Apoptosis by Attenuating RANK/RANKL Signals. | Int J Mol Sci | 2023 | 37373436 | PubTator, text mining | PubMed |
| Cardioprotective Effects of Dexmedetomidine in an Oxidative-Stress In Vitro Model of Neonatal Rat Cardiomyocytes. | Antioxidants (Basel) | 2023 | 37371938 | PubTator, text mining | PubMed |
| Skeletal Muscle MicroRNA Patterns in Response to a Single Bout of Exercise in Females: Biomarkers for Subsequent Training Adaptation? | Biomolecules | 2023 | 37371465 | PubTator, text mining | PubMed |
| The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy? | Cancers (Basel) | 2023 | 37370771 | PubTator, text mining | PubMed |
| A comprehensive review of stroke-related signaling pathways and treatment in western medicine and traditional Chinese medicine. | Front Neurosci | 2023 | 37351420 | PubTator, text mining | PubMed |
| Recent advances in membrane mimetics for membrane protein research. | Biochem Soc Trans | 2023 | 37345653 | PubTator, text mining | PubMed |
| Whole-Genome Doubling as a source of cancer: how, when, where, and why? | Front Cell Dev Biol | 2023 | 37342233 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4485/papers?page=22